Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seema Alam

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Hepatology Communications|June 5, 2024
Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric cirrhosisBabu Mathew, Gaurav Tripathi, Vipul Gautam, et al.
Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasisBikrant Bihari Lal, Seema Alam, Anupam Sibal, et al.
Journal of Clinical and Experimental Hepatology|February 16, 2019
Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of IndiaAabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98]Aabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 23, 2024
Natural course and outcomes of children with ubiquitin-specific protease 53 (USP53)-related genetic chronic cholestasisSeema Alam, Bikrant Bihari Lal, Aathira Ravindranath, et al.
Indian Pediatrics|September 19, 2024
Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN)Vikrant Sood, Seema Alam, Aabha Nagral, et al.
Journal of Clinical and Experimental Hepatology|December 21, 2018
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsAnil Arora, Anil C Anand, Ashish Kumar, et al.
Metabolic Syndrome and Related Disorders|January 27, 2022
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver DiseaseAjay Duseja, Shivaram P Singh, Manu Mehta, et al.
Journal of Clinical and Experimental Hepatology|March 23, 2023
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)Ajay Duseja, S P Singh, Arka De, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Hepatology Communications|June 5, 2024
Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric cirrhosisBabu Mathew, Gaurav Tripathi, Vipul Gautam, et al.
Genetics in Medicine Open|May 25, 2026
Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scoresAnna Paschall, Rebecca L Koch, Alisha M Mavis, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasisBikrant Bihari Lal, Seema Alam, Anupam Sibal, et al.
Journal of Clinical and Experimental Hepatology|February 16, 2019
Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of IndiaAabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98]Aabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 23, 2024
Natural course and outcomes of children with ubiquitin-specific protease 53 (USP53)-related genetic chronic cholestasisSeema Alam, Bikrant Bihari Lal, Aathira Ravindranath, et al.
Indian Pediatrics|September 19, 2024
Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN)Vikrant Sood, Seema Alam, Aabha Nagral, et al.
Journal of Clinical and Experimental Hepatology|December 21, 2018
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or CorticosteroidsAnil Arora, Anil C Anand, Ashish Kumar, et al.
Metabolic Syndrome and Related Disorders|January 27, 2022
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver DiseaseAjay Duseja, Shivaram P Singh, Manu Mehta, et al.
Journal of Clinical and Experimental Hepatology|March 23, 2023
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)Ajay Duseja, S P Singh, Arka De, et al.
Pageof 13